DNMT3A and hematologic disorder: Given the large magnitude of promoter hypomethylation observed in various mouse hematologic malignancies (8, 9, 18, 26), it is possible that loss of Dnmt3a and Dnmt3b maintenance activity drives tumorigenesis due to the inappropriate expression of genes normally silenced.